Vantage Financial Partners (Wisconsin)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$248K Buy
9,942
+62
+0.6% +$1.56K 0.05% 183
2025
Q3
$252K Buy
+9,880
New +$244K 0.05% 182
2025
Q1
– Sell
-8,410
Closed -$223K – 200
2024
Q4
$223K Sell
8,410
-860
-9% -$23.3K 0.06% 158
2024
Q3
$268K Buy
+9,270
New +$270K 0.07% 148

Other funds holding PFE

Vantage Financial Partners (Wisconsin)'s PFE Position: Q4 2025 in Review

Vantage Financial Partners (Wisconsin) increased its Pfizer (PFE) stake by 0.63% in Q4 2025, buying an estimated $1.56K and bringing the position to 9,942 shares worth $248K. The position accounts for 0.05% of the portfolio, ranked #183.

Vantage Financial Partners (Wisconsin) first reported a position in PFE in Q3 2024 and has held it in 4 quarters since. The position peaked at $268K in Q3 2024. 2,922 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Vantage Financial Partners (Wisconsin) held 9,942 shares of Pfizer worth $248K as of Q4 2025.
  • Vantage Financial Partners (Wisconsin) bought 62 Pfizer shares in Q4 2025, an estimated $1.56K.
  • Pfizer made up 0.05% of Vantage Financial Partners (Wisconsin)'s portfolio in Q4 2025, its #183 holding.
  • Vantage Financial Partners (Wisconsin) first reported a position in Pfizer in Q3 2024 and has held it in 4 quarters since.
  • Vantage Financial Partners (Wisconsin)'s Pfizer position peaked at $268K in Q3 2024.
  • 2,922 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Vantage Financial Partners (Wisconsin)'s 13F filing for Q4 2025, filed 3 Feb 2026.